Daily Stock Analysis, VTVT, vTv Therapeutics Inc, priceseries

vTv Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.74
Close
0.65
High
0.74
Low
0.65
Previous Close
0.71
Daily Price Gain
-0.06
YTD High
1.04
YTD High Date
Jan 4, 2022
YTD Low
0.65
YTD Low Date
Mar 7, 2022
YTD Price Change
-0.35
YTD Gain
-34.93%
52 Week High
3.79
52 Week High Date
Apr 13, 2021
52 Week Low
0.65
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-1.70
52 Week Gain
-72.31%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Aug 10. 2017
4.25
Aug 18. 2017
4.58
6 Trading Days
7.84%
Link
LONG
Aug 22. 2017
4.65
Sep 6. 2017
4.95
10 Trading Days
6.45%
Link
LONG
Oct 10. 2017
6.60
Oct 25. 2017
7.01
11 Trading Days
6.17%
Link
LONG
Jan 22. 2018
5.91
Feb 5. 2018
7.34
10 Trading Days
24.20%
Link
LONG
Apr 18. 2018
2.20
Apr 19. 2018
2.33
1 Trading Days
5.91%
Link
LONG
Oct 2. 2018
2.00
Oct 16. 2018
2.90
10 Trading Days
44.79%
Link
LONG
Dec 28. 2018
2.27
Jan 4. 2019
2.41
4 Trading Days
6.06%
Link
LONG
May 15. 2019
1.46
Jun 3. 2019
1.72
12 Trading Days
18.13%
Link
LONG
Sep 9. 2019
1.36
Sep 19. 2019
1.59
8 Trading Days
17.14%
Link
LONG
Dec 19. 2019
1.60
Dec 31. 2019
1.72
7 Trading Days
7.31%
Link
LONG
Jan 13. 2020
1.96
Jan 27. 2020
2.21
9 Trading Days
12.89%
Link
LONG
Feb 19. 2020
2.77
Mar 3. 2020
3.24
9 Trading Days
17.13%
Link
LONG
May 12. 2020
2.56
May 26. 2020
2.71
9 Trading Days
6.00%
Link
LONG
Feb 2. 2021
2.66
Feb 4. 2021
3.12
2 Trading Days
17.48%
Link
Company Information
Stock Symbol
VTVT
Exchange
NasdaqGM
Company URL
http://www.vtvtherapeutics.com
Company Phone
336-841-0300
CEO
Stephen L. Holcombe
Headquarters
North Carolina
Business Address
4170 MENDENHALL OAKS PKWY, HIGH POINT, NC 27265
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001641489
About

vTv Therapeutics, Inc. is a holding company. It is a clinical-stage biopharmaceutical company, which discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. The company portfolio products targets the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. vTv Therapeutics was founded on April 2, 2015 and is headquartered in High Point, NC.

Description

Biotech developing treatments for Alzheimer's disease and type 2 diabetes.